Skip to main content
Sinisa Dovat, MD, Pediatric Hematology & Oncology, Hershey, PA

Sinisa Dovat MD

Pediatric Hematology & Oncology•Hershey, PA

Professor, Pediatrics, Pennsylvania State University College of Medicine

Join to View Full Profile

  • 500 University DrHershey, PA 17033

  • Phone+1 800-243-1455

  • Fax+1 608-263-0440

Dr. Dovat is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Dovat's Full ProfileAlready have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
  • Penn State Milton S Hershey Medical Center
    Penn State Milton S Hershey Medical CenterResidency, Pediatrics, 1993 - 1996
  • University of Novi Sad Faculty of Medicine
    University of Novi Sad Faculty of MedicineClass of 1988

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1996 - Present
  • PA State Medical License
    PA State Medical License 1994 - 2026
  • WI State Medical License
    WI State Medical License 2004 - 2021
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • CK2 Inhibitor CX4945 Shows Strong In Vivo Synergistic Anti-Leukemia Activity with Rapamycin in B-ALL Due to Enhanced Ikaros Mediated Repression of mTOR Pathway
    Sinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • CK2 Inhibitor CX4945 Shows Strong In Vivo Anti Leukemia Effect in AML Via Augmented Ikaros-Mediated Regulation of Global Epigenetic Landscape
    Sinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Oncogenesis of CRLF2 Overexpression and Effect of JAK2 Inhibitor in CRLF2 Overexpressed B-Cell Acute Lymphoblastic Leukemia
    Sinisa Dovat, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • The Novel Small Molecule Inhibitor KS99 Targets AML and Inhibits Stemness Markers STAT3 and ALDH 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • College of Medicine Awarded $4 Million Grant to Advance Pediatric Oncology Research
    College of Medicine Awarded $4 Million Grant to Advance Pediatric Oncology ResearchSeptember 25th, 2024
  • College of Medicine Awarded $4 Million Grant to Advance Pediatric Oncology Research
    College of Medicine Awarded $4 Million Grant to Advance Pediatric Oncology ResearchSeptember 25th, 2024
  • Increased Incidence of IKZF1 Deletions and IGH-CRLF2 Translocations in B-ALL of Hispanic/Latino Children—a Novel Health Disparity
    Increased Incidence of IKZF1 Deletions and IGH-CRLF2 Translocations in B-ALL of Hispanic/Latino Children—a Novel Health DisparityFebruary 2nd, 2021
  • Join now to see all

Grant Support

  • Novel targeted therapy to reduce health disparities in pediatric leukemiaPENNSYLVANIA STATE UNIV HERSHEY MED CTR2023–2028
  • The Role Of Zinc Finger Genes In LeukemogenesisNational Heart, Lung, And Blood Institute2010–2011
  • The Role Of Zinc Finger Genes In LeukemogenesisNational Heart, Lung, And Blood Institute2009–2010
  • The Role Of Zinc Finger Genes In Cellular ProliferationNational Cancer Institute2005–2007
  • The Role Of Zinc Finger Genes In HematopoiesisNational Cancer Institute2003
  • The Role Of Zinc Finger Genes In HematopoiesisNational Cancer Institute1999–2003

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Sinisa Dovat, Dr. Sinisa Dovat, MD, Dr. S Dovat